Basic Chemical and Chemical Product Manufacturing
ANZSIC subdivision 18 · 33 mergers
Total reviews
33
Phase 2 reviews
1
Waivers
11
Under assessment
3
Sub-industries
Mergers in this industry
- Olin - HuntsmanUnder assessment
- Merck KGaA / Bio-TechneUnder assessment
- Zoetis – Neogen Genomics BusinessUnder assessment
- Eli Lilly – Merida BiosciencesApproved
- Lone Star Funds - ContiTechApproved
- Kirin – Jamieson WellnessNot approved
- Novonesis – MicrobiogenApproved
- Saint-Gobain - XypexApproved
- Supagas – Heeson MedicalApproved
- Triton – United InitiatorsApproved
- Wesfarmers and Built Group - Built Living Joint VentureApproved
- Eli Lilly - AtaiBeckley Inc.Approved
- Movac – Advanced NavigationApproved
- Petalite – EnvuApproved
- AbbVie - ApogeeApproved
- Vertex – CrineticsApproved
- Apollo - Bayer Asset ManagementApproved
- Parker-Hannifin – CIRCOR A&DApproved
- Apollo Capital – CuriaApproved
- WHP Global and G-III - Marc JacobsApproved
- CVC Capital Partners and Groupe Bruxelles Lambert – RecordatiApproved
- Henkel – OlaplexApproved
- Eli Lilly - Kelonia TherapeuticsApproved
- Gilead - OuroApproved
- Eli Lilly – acquisition of licence from CSL BehringApproved
- Mayfair Corporation – Phosphate HillApproved
- Francisco Partners - Blackline SafetyApproved
- Eli Lilly - Orna TherapeuticsApproved
- CVC Capital Partners – Marathon Asset ManagementApproved
- Gilead - ArcellxApproved
- Eli Lilly – Orna TherapeuticsNot approved
- Parker-Hannifin – Filtration GroupApproved
- Henkel – ATP adhesive systems groupNot approved